Masutaka Furue

25.5k total citations · 4 hit papers
741 papers, 17.3k citations indexed

About

Masutaka Furue is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Masutaka Furue has authored 741 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 339 papers in Dermatology, 146 papers in Immunology and 125 papers in Immunology and Allergy. Recurrent topics in Masutaka Furue's work include Dermatology and Skin Diseases (181 papers), Allergic Rhinitis and Sensitization (91 papers) and Asthma and respiratory diseases (67 papers). Masutaka Furue is often cited by papers focused on Dermatology and Skin Diseases (181 papers), Allergic Rhinitis and Sensitization (91 papers) and Asthma and respiratory diseases (67 papers). Masutaka Furue collaborates with scholars based in Japan, United States and China. Masutaka Furue's co-authors include Hiroshi Uchi, Takeshi Nakahara, Gaku Tsuji, Takamichi Ito, Yoichi Moroi, Akiko Hashimoto‐Hachiya, Takafumi Kadono, Satoshi Takeuchi, Kazunori Urabe and Takahito Chiba and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Masutaka Furue

685 papers receiving 16.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

2017 414 citations Masutaka Furue et al. profile →
Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus

2012 354 citations Masutaka Furue et al. profile →
Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis

2020 259 citations Masutaka Furue International Journal of Molecular Sciences profile →
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study

2022 99 citations Masutaka Furue et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masutaka Furue Japan	64	8.0k	4.2k	3.8k	3.2k	2.7k	741	17.3k
Kevin D. Cooper United States	70	6.4k 0.8×	6.3k 1.5×	1.6k 0.4×	2.1k 0.6×	1.3k 0.5×	355	14.8k
Yoshiki Miyachi Japan	65	5.0k 0.6×	4.6k 1.1×	1.7k 0.4×	3.8k 1.2×	1.7k 0.6×	506	15.9k
Kenji Kabashima Japan	77	10.9k 1.4×	7.6k 1.8×	6.8k 1.8×	3.1k 1.0×	4.6k 1.7×	483	22.4k
Mübeccel Akdiş Switzerland	76	5.4k 0.7×	6.5k 1.5×	8.5k 2.3×	2.0k 0.6×	8.2k 3.0×	240	19.6k
Thomas Ruzicka Germany	81	11.9k 1.5×	6.2k 1.5×	3.7k 1.0×	5.7k 1.8×	2.6k 0.9×	672	26.2k
Giampiero Girolomoni Italy	81	9.9k 1.2×	12.5k 3.0×	3.8k 1.0×	3.1k 1.0×	3.2k 1.2×	558	23.7k
John J. Voorhees United States	93	15.8k 2.0×	7.7k 1.8×	1.2k 0.3×	8.8k 2.7×	2.3k 0.9×	420	31.1k
Karin Scharffetter‐Kochanek Germany	61	3.8k 0.5×	3.6k 0.8×	1.3k 0.3×	4.4k 1.4×	1.6k 0.6×	294	14.7k
Sewon Kang United States	67	12.8k 1.6×	2.8k 0.7×	983 0.3×	3.4k 1.0×	1.0k 0.4×	227	18.5k
Hans F. Merk Germany	53	3.9k 0.5×	1.4k 0.3×	2.4k 0.6×	1.4k 0.4×	1.3k 0.5×	344	10.2k

Countries citing papers authored by Masutaka Furue

Since Specialization

Citations

This map shows the geographic impact of Masutaka Furue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masutaka Furue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masutaka Furue more than expected).

Fields of papers citing papers by Masutaka Furue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masutaka Furue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masutaka Furue. The network helps show where Masutaka Furue may publish in the future.

Co-authorship network of co-authors of Masutaka Furue

This figure shows the co-authorship network connecting the top 25 collaborators of Masutaka Furue. A scholar is included among the top collaborators of Masutaka Furue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masutaka Furue. Masutaka Furue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyamoto, Kukizo, et al.. (2023). Significant Reversal of Facial Wrinkle, Pigmented Spot and Roughness by Daily Application of Galactomyces Ferment Filtrate-Containing Skin Products for 12 Months—An 11-Year Longitudinal Skin Aging Rejuvenation Study. Journal of Clinical Medicine. 12(3). 1168–1168. 5 indexed citations

Miyamoto, Kukizo, et al.. (2023). Expanded Follicle-Sulcus-Crack Complex Is an Early Warning Sign of Facial Skin Aging: Improvement by Application of <i>Galactomyces</i> Ferment Filtrate-Containing Skin Product. Journal of Cosmetics Dermatological Sciences and Applications. 13(2). 91–106. 1 indexed citations

Hakozaki, Tomohiro, et al.. (2023). Role of interleukin‐6 and endothelin‐1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid. Journal of the European Academy of Dermatology and Venereology. 38(S2). 3–10. 7 indexed citations

Williams, Hywel C, Jochen Schmitt, Kim S Thomas, et al.. (2022). The HOME Core outcome set for clinical trials of atopic dermatitis. Journal of Allergy and Clinical Immunology. 149(6). 1899–1911. 59 indexed citations

Uruno, Takehito, Akihito Harada, Kounosuke Oisaki, et al.. (2021). Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound. Journal of Allergy and Clinical Immunology. 148(2). 633–638. 6 indexed citations

Furue, Masutaka, et al.. (2021). Interleukin-31 and Pruritic Skin. Journal of Clinical Medicine. 10(9). 1906–1906. 38 indexed citations

Furue, Masutaka. (2020). Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis. International Journal of Molecular Sciences. 21(15). 5382–5382. 259 indexed citations breakdown →

Yano, Seiichi, Kenji Ashida, Naoko Wada, et al.. (2019). A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma. American Journal of Case Reports. 20. 106–110. 5 indexed citations

Ito, Takamichi, Yumiko Kaku‐Ito, Maho Murata, et al.. (2019). Intra- and Inter-Tumor BRAF Heterogeneity in Acral Melanoma: An Immunohistochemical Analysis. International Journal of Molecular Sciences. 20(24). 6191–6191. 19 indexed citations

10.

Takeshita, H, et al.. (2018). Schnitzler’s syndrome: A female elderly case presenting intractable non-pruritic febrile urticarial rush. Asian Pacific Journal of Allergy and Immunology. 38(1). 64–66. 1 indexed citations

11.

Uchi, Hiroshi, et al.. (2018). Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes. Oxidative Medicine and Cellular Longevity. 2018(1). 9524657–9524657. 54 indexed citations

12.

Hirano, Akiko, et al.. (2017). Antioxidant Artemisia princeps Extract Enhances the Expression of Filaggrin and Loricrin via the AHR/OVOL1 Pathway. International Journal of Molecular Sciences. 18(9). 1948–1948. 39 indexed citations

13.

Uchi, Hiroshi, et al.. (2016). Inhibition of aryl hydrocarbon receptor signaling and induction of NRF2-mediated antioxidant activity by cinnamaldehyde in human keratinocytes. Journal of Dermatological Science. 85(1). 36–43. 64 indexed citations

14.

Hashimoto‐Hachiya, Akiko, et al.. (2015). Cynaropicrin attenuates UVB-induced oxidative stress via the AhR–Nrf2–Nqo1 pathway. Toxicology Letters. 234(2). 74–80. 79 indexed citations

15.

Zhu, Li, et al.. (2014). Upregulated Expression of Calcyclin-Binding Protein/Siah-1 Interacting Protein in Malignant Melanoma. Annals of Dermatology. 26(5). 670–670. 6 indexed citations

16.

Furue, Masutaka, Yasumi Kitahara, Hideto Akama, et al.. (2014). Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in J apanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial. The Journal of Dermatology. 41(7). 577–585. 68 indexed citations

17.

Takao, Tomoka, Ryosuke Tsunematsu, Seiichi Morokuma, et al.. (2012). Inhibition of AHR transcription by NF1C is affected by a single-nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer. Oncogene. 32(41). 4950–4959. 27 indexed citations

18.

Kurihara, Yuichi, Hiroyoshi Inoue, Hiromaro Kiryu, & Masutaka Furue. (2012). Epithelioid hemangioma (Angiolymphoid hyperplasia with eosinophilia) in zosteriform distribution. Indian Journal of Dermatology. 57(5). 401–401. 12 indexed citations

19.

Arata, Jirô, Hiroshi Shimizu, Shinichi Watanabe, et al.. (2005). Clinical evaluation of telithromycin in patients with skin and soft tissue infections. Phase III double-blind comparative study of telithromycin versus cefdinir. 53(3). 183–206. 2 indexed citations

20.

Furue, Masutaka. (1994). Atopic dermatitis—immunological abnormality and its background. Journal of Dermatological Science. 7(3). 159–168. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact